A carregar...
Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors
AIMS: We evaluated the effects of patiromer, a potassium (K(+))‐binding polymer, in a pre‐specified analysis of hyperkalaemic patients with heart failure (HF) in the OPAL‐HK trial. METHODS AND RESULTS: Chronic kidney disease (CKD) patients on renin–angiotensin–aldosterone system inhibitors (RAASi) w...
Na minha lista:
| Publicado no: | Eur J Heart Fail |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5057342/ https://ncbi.nlm.nih.gov/pubmed/26459796 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.402 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|